These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1734910)
21. Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles. Tan FK; Arnett FC; Reveille JD; Ahn C; Antohi S; Sasaki T; Nishioka K; Bona CA Arthritis Rheum; 2000 Nov; 43(11):2464-71. PubMed ID: 11083269 [TBL] [Abstract][Full Text] [Related]
22. Anti-U3 RNP autoantibodies in systemic sclerosis. Aggarwal R; Lucas M; Fertig N; Oddis CV; Medsger TA Arthritis Rheum; 2009 Apr; 60(4):1112-8. PubMed ID: 19333934 [TBL] [Abstract][Full Text] [Related]
24. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis. Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166 [TBL] [Abstract][Full Text] [Related]
25. The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis. Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K J Invest Dermatol; 2003 Feb; 120(2):204-10. PubMed ID: 12542523 [TBL] [Abstract][Full Text] [Related]
26. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Steen VD; Powell DL; Medsger TA Arthritis Rheum; 1988 Feb; 31(2):196-203. PubMed ID: 3348823 [TBL] [Abstract][Full Text] [Related]
28. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients. Satoh M; Kuwana M; Ogasawara T; Ajmani AK; Langdon JJ; Kimpel D; Wang J; Reeves WH J Immunol; 1994 Dec; 153(12):5838-48. PubMed ID: 7989779 [TBL] [Abstract][Full Text] [Related]
29. The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma. Sato H; Lagan AL; Alexopoulou C; Vassilakis DA; Ahmad T; Pantelidis P; Veeraraghavan S; Renzoni E; Denton C; Black C; Wells AU; du Bois RM; Welsh KI Arthritis Rheum; 2004 Feb; 50(2):558-64. PubMed ID: 14872499 [TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arnett FC; Reveille JD; Goldstein R; Pollard KM; Leaird K; Smith EA; Leroy EC; Fritzler MJ Arthritis Rheum; 1996 Jul; 39(7):1151-60. PubMed ID: 8670324 [TBL] [Abstract][Full Text] [Related]
31. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis. Mendes C; Viana VST; Pasoto SG; Leon EP; Bonfa E; Sampaio-Barros PD Clin Rheumatol; 2020 Jan; 39(1):9-17. PubMed ID: 31065858 [TBL] [Abstract][Full Text] [Related]
32. Antibodies in scleroderma: direct pathogenicity and phenotypic associations. Chung L; Utz PJ Curr Rheumatol Rep; 2004 Apr; 6(2):156-63. PubMed ID: 15016347 [TBL] [Abstract][Full Text] [Related]
33. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Jacobsen S; Halberg P; Ullman S; Van Venrooij WJ; Høier-Madsen M; Wiik A; Petersen J Br J Rheumatol; 1998 Jan; 37(1):39-45. PubMed ID: 9487249 [TBL] [Abstract][Full Text] [Related]
35. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769 [TBL] [Abstract][Full Text] [Related]
36. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study. Valenzuela A; Baron M; ; Herrick AL; Proudman S; Stevens W; ; Rodriguez-Reyna TS; Vacca A; Medsger TA; Hinchcliff M; Hsu V; Wu JY; Fiorentino D; Chung L Semin Arthritis Rheum; 2016 Dec; 46(3):344-349. PubMed ID: 27371996 [TBL] [Abstract][Full Text] [Related]